Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-548 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-541 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate |
2005-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2008-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2008511544-A |
titleOfInvention |
Pharmaceutical composition for controlled release delivery of bioactive compounds |
abstract |
The present invention provides compositions and methods for controlled release delivery of one or more bioactive compounds to a subject. Specifically, the present invention is a pharmaceutical composition for controlled release delivery of a bioactive compound to a subject, comprising the following components: a) a bioactive compound having at least one basic functional group, and at least Provided is a pharmaceutical composition comprising a complex with a polyanion derived from hexahydroxycyclohexane having two negatively charged functional groups; and b) a pharmaceutically acceptable carrier comprising a biodegradable water-insoluble polymer. . By complexing the bioactive compound with the polyanion, a robust and stable complex can be incorporated into a long acting administration system having a more desirable time-course drug release curve found in the prior art. The present invention also provides methods for producing such compositions and methods of use thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10500163-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010235616-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016028066-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012524779-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011530568-A |
priorityDate |
2004-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |